Combination of isocitrate dehydrogenase 1 ( IDH 1 ) mutation and podoplanin expression in brain tumors identifies patients at high or low risk of venous thromboembolism-Reference-Cited by-同舟云学术

Combination of isocitrate dehydrogenase 1 ( IDH 1 ) mutation and podoplanin expression in brain tumors identifies patients at high or low risk of venous thromboembolism

Published:2018-05-20 Issue:6 Volume:16 Page:1121-1127
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Mir Seyed Nazari P.¹,Riedl J.¹,Preusser M.²,Posch F.¹³,Thaler J.¹,Marosi C.²,Birner P.⁴,Ricken G.⁵,Hainfellner J. A.⁵,Pabinger I.¹,Ay C.¹^ORCID

Affiliation:

1. Clinical Division of Hematology and Hemostaseology Department of Medicine I Comprehensive Cancer Center Center Medical University of Vienna Vienna Austria

2. Clinical Division of Oncology Department of Medicine I Comprehensive Cancer Center Medical University of Vienna Vienna Austria

3. Division of Oncology Department of Internal Medicine Medical University of Graz Graz Austria

4. Clinical Institute of Pathology Medical University of Vienna Vienna Austria

5. Institute of Neurology Medical University of Vienna Vienna Austria

Funder

Austrian Science Fund

Oesterreichische Nationalbank

Publisher

Wiley

Subject

Hematology

Link